Long-Term Debt

9 Months Ended

Sep. 30, 2024

6. LONG-TERM DEBT

The principal components of long-term debt are as follows (in millions):


	September 30, 2024		December 31, 2023
3.3%, Senior Notes due 2027	$	400.0	$	400.0
3.7%, Senior Notes due 2032	800.0		800.0
Less unamortized discounts and debt issuance costs	(9.2)		(10.5)
Long-term debt less unamortized discounts and debt issuance costs	1,190.8		1,189.5
Finance leases and other debt	10.6		10.1
Less current maturities	(1.3)		(0.5)
Long-term debt	$	1,200.1	$	1,199.1

On February 13, 2024, we entered into a new $200.0 million unsecured revolving credit agreement ("Revolving Credit Agreement") with a group of financial institutions. The Revolving Credit Agreement replaced the Company's previous credit agreement, dated as of April 15, 2019. Borrowings under the Revolving Credit Agreement are on a revolving basis and can be used to make acquisitions, for working capital and for other general corporate purposes. The Revolving Credit Agreement requires Bio-Rad to comply with certain financial ratios and other customary covenants and provisions. The Revolving Credit Agreement matures on February 13, 2029. As of September 30, 2024, no borrowings were outstanding under the Revolving Credit Agreement, although available capacity was reduced by immaterial outstanding letters of credit. As of September 30, 2024, we were in compliance with the covenants for the Revolving Credit Agreement.